Breast cancers high cyclin cyclin e. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy17

Breast Cell Line, Tumor Tumor Cells, Cultured MCF-7 Cells Cell Line Mammary Glands, Human Axilla Cell Nucleus Epithelial Cells Fibroblasts Lymph Nodes Cells, Cultured Nipples Neoplastic Stem Cells HeLa Cells Mammary Glands, Animal 3T3 Cells

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases32

Breast Neoplasms Carcinoma, Ductal, Breast Breast Diseases Neoplasm Invasiveness Neoplasm Metastasis Breast Neoplasms, Male Carcinoma, Lobular Carcinoma Mammary Neoplasms, Experimental Carcinoma, Intraductal, Noninfiltrating Genetic Predisposition to Disease Ovarian Neoplasms Lymphatic Metastasis Neoplasms, Hormone-Dependent Lung Neoplasms Neoplasm Recurrence, Local Neoplasms Cell Transformation, Neoplastic Disease Progression Prostatic Neoplasms Fibrocystic Breast Disease Colonic Neoplasms Bone Neoplasms Stomach Neoplasms Adenocarcinoma Carcinoma, Ductal Carcinoma in Situ Pancreatic Neoplasms Neoplasms, Second Primary Triple Negative Breast Neoplasms Carcinoma, Squamous Cell Inflammatory Breast Neoplasms

Chemicals and Drugs90

Cyclin E Cyclin D1 Cyclin A Cyclin B Cyclin B1 Cyclin D3 Cyclin D2 Cyclin A1 Cyclin D Cyclin A2 Cyclins Cyclin-Dependent Kinase 2 Cyclin-Dependent Kinases Cyclin G1 Cyclin G CDC2-CDC28 Kinases Receptors, Estrogen Cyclin C Receptor, erbB-2 Cell Cycle Proteins Cyclin B2 Cyclin-Dependent Kinase 4 Cyclin-Dependent Kinase Inhibitor p27 Tamoxifen Receptors, Progesterone Cyclin T Tumor Markers, Biological Retinoblastoma Protein Cyclin G2 Cyclin H Oncogene Proteins Neoplasm Proteins Protein-Serine-Threonine Kinases RNA, Messenger Antineoplastic Agents CDC2 Protein Kinase Antineoplastic Agents, Hormonal Tumor Suppressor Proteins Cyclin-Dependent Kinase Inhibitor p21 Estrogens Tumor Suppressor Protein p53 RNA, Small Interfering Estrogen Receptor alpha F-Box Proteins Transcription Factors Cyclin-Dependent Kinase 6 DNA-Binding Proteins Proto-Oncogene Proteins Cyclin I BRCA2 Protein Nuclear Proteins Estrogen Antagonists Ki-67 Antigen BRCA1 Protein E2F Transcription Factors DNA, Neoplasm Aromatase Inhibitors Estrogen Receptor Modulators Microtubule-Associated Proteins Estradiol Fluorouracil Nitriles Enzyme Inhibitors Antibodies, Monoclonal, Humanized E2F1 Transcription Factor Proliferating Cell Nuclear Antigen Cyclophosphamide Antibodies, Monoclonal Proto-Oncogene Proteins c-myc DNA Primers RNA, Neoplasm Selective Estrogen Receptor Modulators Epirubicin Cyclin-Dependent Kinase Inhibitor p16 Retinoblastoma-Binding Protein 1 Carrier Proteins Receptor, Epidermal Growth Factor Transcription Factor DP1 Proto-Oncogene Proteins c-akt Anticarcinogenic Agents Paclitaxel cdc25 Phosphatases Antigens, Neoplasm MicroRNAs S-Phase Kinase-Associated Proteins Protein Kinases Retinoblastoma-Like Protein p107 Cancer Vaccines Protein Isoforms Ubiquitin-Protein Ligases

Analytical, Diagnostic and Therapeutic Techniques and Equipment60

Prognosis Mammography Immunohistochemistry Neoplasm Staging Early Detection of Cancer Blotting, Western Mastectomy Reverse Transcriptase Polymerase Chain Reaction Risk Factors Chemotherapy, Adjuvant Survival Analysis Mammary Neoplasms, Experimental Gene Expression Profiling Case-Control Studies Transfection Antineoplastic Combined Chemotherapy Protocols Disease-Free Survival Survival Rate Breast Self-Examination Follow-Up Studies Risk Retrospective Studies Prospective Studies Risk Assessment Xenograft Model Antitumor Assays Mastectomy, Segmental Odds Ratio Treatment Outcome Incidence Oligonucleotide Array Sequence Analysis Multivariate Analysis Tissue Array Analysis Models, Biological Transplantation, Heterologous Cohort Studies Neoplasm Transplantation Immunoenzyme Techniques Sensitivity and Specificity Registries Polymerase Chain Reaction Flow Cytometry Predictive Value of Tests Ultrasonography, Mammary Kaplan-Meier Estimate Tumor Burden Gene Knockdown Techniques SEER Program Immunoblotting Questionnaires Logistic Models In Situ Hybridization, Fluorescence Combined Modality Therapy Breast Implants Neoplasm Grading Reproducibility of Results Mass Screening Radiotherapy, Adjuvant Mammaplasty Confidence Intervals Proportional Hazards Models

Psychiatry and Psychology2

Breast Feeding Breast Self-Examination

Phenomena and Processes51

Cell Cycle Gene Expression Regulation, Neoplastic G1 Phase S Phase Cell Proliferation Cell Division Phosphorylation Genes, BRCA1 Postmenopause Apoptosis Signal Transduction Mutation Drug Resistance, Neoplasm Down-Regulation Genetic Predisposition to Disease Transfection Breast Feeding Mitosis Premenopause Promoter Regions, Genetic Time Factors Risk Menopause Genes, BRCA2 Genes, erbB-2 Base Sequence Genes, bcl-1 Up-Regulation RNA Interference Odds Ratio Gene Expression G2 Phase Transcription, Genetic Protein Binding Cell Growth Processes Gene Amplification Cell Movement Sensitivity and Specificity Dose-Response Relationship, Drug G0 Phase Genotype Phenotype Amino Acid Sequence Enzyme Activation Cell Survival Gene Silencing Gene Expression Regulation Germ-Line Mutation Polymorphism, Genetic DNA Methylation Genes, Tumor Suppressor

Disciplines and Occupations1

Immunohistochemistry

Information Science8

Survival Rate Molecular Sequence Data Base Sequence Incidence Registries Amino Acid Sequence SEER Program Questionnaires

Named Groups1

Health Care27

Risk Factors Survival Analysis Case-Control Studies Disease-Free Survival Survival Rate Follow-Up Studies Risk Retrospective Studies Prospective Studies Risk Assessment Age Factors Odds Ratio Treatment Outcome Incidence Multivariate Analysis Cohort Studies Sensitivity and Specificity Registries Predictive Value of Tests Kaplan-Meier Estimate SEER Program Questionnaires Logistic Models Reproducibility of Results Mass Screening Confidence Intervals Proportional Hazards Models

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Information Science Named Groups Health Care Geographicals

Cyclin E Cyclin D1 Cyclin A Cyclin B Breast Neoplasms Breast Cyclin B1 Cyclin D3 Cyclin D2 Cyclin A1 Cyclin D Prognosis Cyclin A2 Cyclins Cyclin-Dependent Kinase 2 Cyclin-Dependent Kinases Cyclin G1 Cyclin G Carcinoma, Ductal, Breast CDC2-CDC28 Kinases Cell Line, Tumor Cell Cycle Receptors, Estrogen Gene Expression Regulation, Neoplastic Cyclin C G1 Phase Receptor, erbB-2 Cell Cycle Proteins Cyclin B2 Cyclin-Dependent Kinase 4 Breast Diseases Cyclin-Dependent Kinase Inhibitor p27 Tamoxifen S Phase Receptors, Progesterone Cyclin T Mammography Tumor Markers, Biological Cell Proliferation Neoplasm Invasiveness Neoplasm Metastasis Retinoblastoma Protein Cyclin G2 Tumor Cells, Cultured Cyclin H Oncogene Proteins Neoplasm Proteins Immunohistochemistry Cell Division Protein-Serine-Threonine Kinases RNA, Messenger Antineoplastic Agents Neoplasm Staging CDC2 Protein Kinase Breast Neoplasms, Male Phosphorylation Antineoplastic Agents, Hormonal Tumor Suppressor Proteins Mice, Nude Early Detection of Cancer Blotting, Western Mastectomy Cyclin-Dependent Kinase Inhibitor p21 Reverse Transcriptase Polymerase Chain Reaction Genes, BRCA1 Risk Factors Postmenopause Carcinoma, Lobular Chemotherapy, Adjuvant Apoptosis Survival Analysis Signal Transduction Mutation Drug Resistance, Neoplasm MCF-7 Cells Carcinoma Estrogens Tumor Suppressor Protein p53 RNA, Small Interfering Mammary Neoplasms, Experimental Carcinoma, Intraductal, Noninfiltrating Down-Regulation Estrogen Receptor alpha Gene Expression Profiling Genetic Predisposition to Disease Ovarian Neoplasms Case-Control Studies Transfection F-Box Proteins Antineoplastic Combined Chemotherapy Protocols Breast Feeding Mitosis Disease-Free Survival Premenopause Lymphatic Metastasis Neoplasms, Hormone-Dependent Lung Neoplasms Transcription Factors Promoter Regions, Genetic Time Factors

No FAQ available that match "breast cancers high cyclin cyclin e"